Drug name - Makena
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9180259 | COVIS | Prefilled syringe jet injector |
Jan, 2026
(3 years from now) | |
| US9629959 | COVIS | Prefilled syringe jet injector |
Jan, 2026
(3 years from now) | |
| US8562564 | COVIS | Prefilled syringe jet injector |
Jan, 2026
(3 years from now) | |
| US9533102 | COVIS | Prefilled syringe jet injector |
Jan, 2026
(3 years from now) | |
| US8021335 | COVIS | Prefilled syringe jet injector |
Oct, 2026
(3 years from now) | |
| US9789257 | COVIS | Needle assisted injection device having reduced trigger force |
Feb, 2034
(11 years from now) | |
| US11154562 | COVIS | Methods of reducing risk of preterm birth |
May, 2036
(13 years from now) | |
| US10471075 | COVIS | Methods of reducing risk of preterm birth |
May, 2036
(13 years from now) | |
| US9844558 | COVIS | Methods of reducing risk of preterm birth |
May, 2036
(13 years from now) | |
Drugs and Companies using HYDROXYPROGESTERONE CAPROATE ingredient
Treatment: Reducing the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth
Dosage: SOLUTION;INTRAMUSCULAR; SOLUTION;SUBCUTANEOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 1250MG/5ML (250MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription |
| 250MG/ML (250MG/ML) | SOLUTION;INTRAMUSCULAR | Prescription |
| 275MG/1.1ML (250MG/ML) | SOLUTION;SUBCUTANEOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.